3 天前 - … models allows us to select the most adapted model for our population [… population
pharmacokinetic models for piperacillin in neonates using clinical data collected for preterm …

8 天前 - … bioavailability of midazolam in children, four were based … population PK approach.
The difficulty of performing crossover bioavailability studies in neonates and young children …

12 天前 - … antibiotic exposures used published population pharmacokinetic models within
drug-specific neonatal intensive care unit cohorts of preterm and term infants, postnatal age 7–…

32 天前 - … Population pharmacokinetic characteristics of amikacin in suspected cases of
neonatal sepsis in a low-resource African setting: A prospective nonrandomized single-site study. …

48 天前 - … model for Japanese premature infants and comparing it with previously reported
pe … -and-comparing-it-with-previously-reported-pediatric-population-pharmacokineticmodels …

50 天前 - … population pharmacokinetic analysis for oral and intravenous clavulanic acid in (pre-)term
neonates… It was demonstrated that clavulanic acid bioavailability is lower in neonates …

65 天前 - … arteriosus (PDA) in preterm infants when ibuprofen is contraindicated.…
pharmacokinetics and pharmacodynamics of paracetamol for hsPDA closure in extreme preterm …

65 天前 - … Its ultra-long half-life and stable pharmacokinetic profile … in this vulnerable population
of extreme preterm infants. … transient neonatal hyperglycemia in extreme premature infants…

84 天前 - … ROP currently occurring in larger preterm infants should be preventable. Avoidance
of unblended 100% oxygen during postdelivery stabilisation and neonatal care, with careful …

97 天前 - … the PK profiles with absolute average fold error (AAFE) < 2, especially our intravenous
PBPK model that extended the predicted age to preterm. … for preterm and term neonates, …